A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
D. Amadori, C. Milandri, G. Comella, S. Saracchini, S. Salvagni, C. Barone, R. Bordonaro, V. Gebbia, A. Barbato, P. Serra, D. Gattuso, O. Nanni, B. Baconnet, G. GaspariniVolume:
47
Year:
2011
Language:
english
Pages:
2099
DOI:
10.1016/j.ejca.2011.05.005
File:
PDF, 226 KB
english, 2011